John G. Quinn

ORCID: 0000-0002-4664-6232
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Monoclonal and Polyclonal Antibodies Research
  • Advanced Biosensing Techniques and Applications
  • Biosensors and Analytical Detection
  • Protein purification and stability
  • Advanced biosensing and bioanalysis techniques
  • Antibiotic Resistance in Bacteria
  • Receptor Mechanisms and Signaling
  • Protein Kinase Regulation and GTPase Signaling
  • Microfluidic and Capillary Electrophoresis Applications
  • Ubiquitin and proteasome pathways
  • Protein Degradation and Inhibitors
  • Lipoproteins and Cardiovascular Health
  • RNA and protein synthesis mechanisms
  • Listeria monocytogenes in Food Safety
  • Vibrio bacteria research studies
  • Peptidase Inhibition and Analysis
  • Plasmonic and Surface Plasmon Research
  • Force Microscopy Techniques and Applications
  • Molecular Junctions and Nanostructures
  • 14-3-3 protein interactions
  • Cell death mechanisms and regulation
  • Computational Drug Discovery Methods
  • Melanoma and MAPK Pathways
  • Drug Transport and Resistance Mechanisms
  • Protein Structure and Dynamics

Beaumont Hospital
2024

Dublin City University
1999-2022

Cellular Biomedicine Group (United States)
2021

Michael & Associates
2012

Teledyne FLIR (United States)
2011

Stanger Hospital
2006

Texas Instruments (United States)
2002-2003

University of Ulster
1980

ABSTRACT The outer membrane is an essential structural component of Gram-negative bacteria that composed lipoproteins, lipopolysaccharides, phospholipids, and integral β-barrel proteins. A dedicated machinery, called the Lol system, ensures proper trafficking lipoproteins from inner to membrane. LolCDE ABC transporter component, which for bacterial viability. Here, we report a novel pyrrolopyrimidinedione compound, G0507, was identified in phenotypic screen inhibitors Escherichia coli growth...

10.1128/aac.02151-17 article EN Antimicrobial Agents and Chemotherapy 2018-01-11
Rebecca L. Rich Giuseppe A. Papalia Peter J. Flynn Jamie Furneisen John G. Quinn and 95 more Joshua S. Klein Phinikoula S. Katsamba M. Brent Waddell Michael J. Scott Joshua Thompson Judie Berlier Schuyler Corry Mireille Baltzinger Gabrielle Zeder‐Lutz Andreas Schoenemann Anca Clabbers Sébastien Wieckowski Mary M. Murphy Phillip C. Bulman Page Thomas E. Ryan Jay Duffner Tanmoy Ganguly John Corbin Satyen Gautam Gregor Anderluh Andrej Bavdek Dana Reichmann Satya Prakash Yadav Eric Hommema Ewa Pol Andrew W. Drake Scott L. Klakamp Trevor Chapman Dawn Kernaghan Ken Miller Jason T. Schuman Kevin C. Lindquist Kara Herlihy Michael Murphy Richard N. Bohnsack Bruce Andrien Pietro Brandani Danny Terwey Rohn Millican Ryan J. Darling Liann Wang Quincy Carter Joe E. Dotzlaf Jacinto López‐Sagaseta Islay Campbell Paola Torreri Sylviane Hoos Patrick England Yang Liu Yasmina Abdiche Daniel Malashock Alanna Pinkerton Melanie Wong Eileen M. Lafer Cynthia S. Hinck Kevin Thompson Carmelo Di Primo Alison Joyce Jonathan Brooks Federico Torta Anne Birgitte Bagge Hagel Janus Krarup Jesper Pass Mônica Spadafora-Ferreira Sergei Shikov Malgorzata G. Mikolajczyk Yuki Abe Gaetano Barbato Anthony M. Giannetti Ganeshram Krishnamoorthy Bianca Beusink Daulet K. Satpaev Tiffany Tsang Eric Fang J. E. Partridge Stephen G. Brohawn James R. Horn Otto Pritsch Gonzalo Obal S. Nilapwar Ben Busby Gerardo Gutiérrez‐Sánchez Ruchira Das Gupta Sylvie Canépa Krista Witte Zaneta Nikolovska‐Coleska Yun Hee Cho Roberta D’Agata Kristian H. Schlick R. Calvert Eva Muñoz María J. Hernáiz Tsafir Bravman Monica Dines Min-Hsiang Yang

10.1016/j.ab.2008.11.021 article EN Analytical Biochemistry 2008-11-28

The Ras-RAF-MEK-ERK signaling axis, commonly mutated in human cancers, is highly regulated to prevent aberrant healthy cells. One of the pathway modulators, 14–3–3, a constitutive dimer, induces RAF dimerization and activation by binding phosphorylated motif C-terminal kinase domain. Recent work has suggested that "DTS" region BRAF necessary for this 14–3–3-mediated activation. We show catalytic activity ATP affinity BRAF:14–3–3 complex insensitive presence or absence DTS, while sites both...

10.1021/acs.biochem.0c00517 article EN Biochemistry 2020-09-24

With recent advances and success in several drugs designed to treat acute chronic diseases, targeted covalent inhibitors show a resurgence drug discovery. As inhibition is time-dependent, the preferred quantitative potency metric of irreversible second-order rate constant kinact/Ki, rather than IC50. Here, we present development mass spectrometry-based platform for rapid kinetic analysis inhibitors. Using simple liquid handling robot automated sample preparation solid-phase extraction-based...

10.1021/acs.analchem.1c04463 article EN Analytical Chemistry 2022-01-06

The von Hippel–Lindau (VHL) protein plays a pivotal role in regulating the hypoxic stress response and has been extensively studied utilized targeted degradation field, particularly context of bivalent degraders. In this study, we present comprehensive peptidomimetic structure–activity relationship (SAR) approach, combined with cellular NanoBRET target engagement assays to enhance existing VHL ligands. Through systematic modifications molecule, identified 1,2,3-triazole group as an optimal...

10.1021/acs.jmedchem.3c02203 article EN Journal of Medicinal Chemistry 2024-05-29

Background: Divarasib, a covalent inhibitor targeting the Kirsten rat sarcoma virus oncogene homologue glycine-to-cysteine mutation at position 12 (KRAS G12C), is currently in clinical development for Non Small Cell Lung Cancer (NSCLC) treatment, with various combination partners, such as Src homology region 2 domain-containing phosphatase-2 (SHP2) migoprotafib. A quantitative systems pharmacology (QSP) model essential to quantitatively assess single-agent and pharmacodynamic (PD) effects...

10.70534/qjsh1938 article EN 2025-02-18

Developing small-molecule (SM) therapeutics that target membrane proteins (MPs) is often challenging, because few biophysical methods can handle the detergents required to maintain stability. Here, we report a surface plasmon resonance (SPR)-based methodology enables characterization of interactions between SMs and an ion channel receptor (MP1) in complex with stabilizing antibody fragment (Fab) surfactant. Briefly, stable MP1-Fab was formed by coimmobilizing MP1 anti-MP1-Fab within hydrogel...

10.1021/acs.analchem.4c06339 article EN Analytical Chemistry 2025-02-24

Achieving sufficient pathway suppression for low-abundance cytokines like VEGF may require depletion to femtomolar concentrations using high-affinity antagonists. Understanding the kinetics of this pharmacodynamically complex process is important development anti-VEGF therapeutic molecules Ranibizumab and requires experimental determination kinetic binding constants VEGF-antagonist complex. These measurements are challenging due extremely high affinities, long residence times, a need mimic...

10.1021/acs.analchem.4c06023 article EN Analytical Chemistry 2025-03-17

In label-free biomolecular interaction analysis, a standard injection provides an of uniform analyte concentration. An alternative approach exploiting Taylor dispersion produces continuous titration allowing full dose response to be recorded in single injection. The enhanced biophysical characterization that is possible with this new technique demonstrated using commercially available surface plasmon resonance-based biosensor. A kinetic model was fitted locally curves for estimation the...

10.1016/j.ab.2011.11.023 article EN cc-by-nc-nd Analytical Biochemistry 2011-12-05

Necroptotic cell death is promoted by the dimerization-dependent activation of kinase RIPK3.

10.1126/scisignal.aar2188 article EN Science Signaling 2018-08-21
Coming Soon ...